{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:30:56Z","timestamp":1786113056606,"version":"build-2736575974"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,9]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>To report a rare case of primary hyperaldosteronism initially presenting with bilateral branch retinal vein occlusion (BRVO).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>Having a 17-year history of poorly controlled hypertension, a 62-year-old male patient suffered from recurrent macular edema secondary to bilateral BRVO.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>Laboratory tests revealed elevated plasma aldosterone concentration, lowered direct renin concentration, and an augmented aldosterone-to-renin ratio, with no suppression of plasma aldosterone on the Captopril test (15.2\u2009ng\/dL to 16.1\u2009ng\/dL). Diagnosis of bilateral BRVO with recurrent macular edema was further confirmed by ocular imaging, which predominantly comprised optical coherence tomography and fluorescein angiography.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>The patient received systemic antihypertensive therapy. Ocular treatment included multiple intravitreal anti-vascular endothelial growth factor injections and dexamethasone implants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>In the aftermath of combined systemic and intravitreal therapy, blood pressure was controlled, and the condition remained acceptably stable throughout follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>This case sufficiently underscored the significance of systemic screening in patients with BRVO, especially those with refractory hypertension. It has been proven to be effective when systemic and intravitreal therapy are integrated, and long-term management is essential for the clinical treatments.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000046990","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:01:28Z","timestamp":1767988888000},"page":"e46990","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Primary hyperaldosteronism with bilateral branch retinal vein occlusion as the initial presentation: A case report"],"prefix":"10.1097","volume":"105","author":[{"given":"Xiwen","family":"Ji","sequence":"first","affiliation":[{"name":"Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Mu","sequence":"additional","affiliation":[{"name":"Qian Xi Nan People\u2019s Hospital, Guizhou, P. R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyang","family":"Wang","sequence":"additional","affiliation":[{"name":"Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Yang","sequence":"additional","affiliation":[{"name":"Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4093-2828","authenticated-orcid":false,"given":"Chunli","family":"Chen","sequence":"additional","affiliation":[{"name":"Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260805","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMcp1003934","article-title":"Retinal-vein occlusion.","volume":"363","author":"Wong","year":"2010","journal-title":"N Engl J Med"},{"key":"R2-20260805","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.preteyeres.2004.12.001","article-title":"Prevalent misconceptions about acute retinal vascular occlusive disorders.","volume":"24","author":"Hayreh","year":"2005","journal-title":"Prog Retin Eye Res"},{"key":"R3-20260805","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ophtha.2009.07.017","article-title":"The prevalence of retinal vein occlusion: pooled data from population studies from the united states, europe, asia, and australia.","volume":"117","author":"Rogers","year":"2010","journal-title":"Ophthalmology"},{"key":"R4-20260805","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.ophtha.2010.01.058","article-title":"Natural history of branch retinal vein occlusion: an evidence-based systematic review.","volume":"117","author":"Rogers","year":"2010","journal-title":"Ophthalmology"},{"key":"R5-20260805","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ophtha.2004.10.039","article-title":"Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli: the atherosclerosis risk in communities & cardiovascular health studies.","volume":"112","author":"Wong","year":"2005","journal-title":"Ophthalmology"},{"key":"R6-20260805","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0002-9394(00)00709-1","article-title":"Systemic diseases associated with various types of retinal vein occlusion.","volume":"131","author":"Hayreh","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"R7-20260805","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1210\/jc.2016-1472","article-title":"Study heterogeneity and estimation of prevalence of primary aldosteronism: a systematic review and meta-regression analysis.","volume":"101","author":"K\u00e4yser","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"R8-20260805","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline.","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"R9-20260805","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ejim.2011.05.004","article-title":"Endocrine hypertension--current understanding and comprehensive management review.","volume":"22","author":"Sukor","year":"2011","journal-title":"Eur J Intern Med"},{"key":"R10-20260805","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.","volume":"89","author":"Mulatero","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R11-20260805","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.HYP.0000079505.25750.11","article-title":"Primary aldosteronism and hypertensive disease.","volume":"42","author":"Mosso","year":"2003","journal-title":"Hypertension"},{"key":"R12-20260805","doi-asserted-by":"crossref","first-page":"1147225","DOI":"10.3389\/fendo.2023.1147225","article-title":"Primary hyperaldosteronism is associated with increased mortality and morbidity in patients with hypertension and diabetes.","volume":"14","author":"Pillai","year":"2023","journal-title":"Front Endocrinol"},{"key":"R13-20260805","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1161\/01.HYP.0000184231.84465.62","article-title":"Low-renin hypertension with relative aldosterone excess is associated with impaired NO-mediated vasodilation.","volume":"46","author":"Duffy","year":"2005","journal-title":"Hypertension"},{"key":"R14-20260805","doi-asserted-by":"crossref","first-page":"NP44","DOI":"10.1177\/1120672121991399","article-title":"The association of aldosterone with papillophlebitis and retinal artery occlusion: a case report.","volume":"34","author":"Kuo","year":"2024","journal-title":"Eur J Ophthalmol"},{"key":"R15-20260805","first-page":"e43195","article-title":"Hyperaldosteronism presenting with unilateral blindness: a case report.","volume":"15","author":"Manuel","year":"2023","journal-title":"Cureus"},{"key":"R16-20260805","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0002-9394(14)74554-4","article-title":"Anatomy of arteriovenous crossings in branch retinal vein occlusion.","volume":"109","author":"Weinberg","year":"1990","journal-title":"Am J Ophthalmol"},{"key":"R17-20260805","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/archopht.1982.01030040110020","article-title":"Histopathologic study of nine branch retinal vein occlusions.","volume":"100","author":"Frangieh","year":"1982","journal-title":"Archives of ophthalmology (Chicago, Ill. : 1960)"},{"key":"R18-20260805","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1442-9071.1993.tb00959.x","article-title":"An anatomical study of retinal arteriovenous crossings and their role in the pathogenesis of retinal branch vein occlusions.","volume":"21","author":"Jefferies","year":"1993","journal-title":"Aust N Z J Ophthalmol"},{"key":"R19-20260805","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/S0161-6420(99)90483-9","article-title":"Pathophysiology and hemodynamics of branch retinal vein occlusion.","volume":"106","author":"Christoffersen","year":"1999","journal-title":"Ophthalmology"},{"key":"R20-20260805","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0002-9394(84)90316-7","article-title":"Argon laser photocoagulation for macular edema in branch vein occlusion. The branch vein occlusion study group.","volume":"98","author":"Frank","year":"1984","journal-title":"Am J Ophthalmol"},{"key":"R21-20260805","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.1167\/iovs.15-17678","article-title":"Prediction of retinal ischemia in branch retinal vein occlusion: spectral-domain optical coherence tomography study.","volume":"56","author":"Lim","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R22-20260805","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1177\/112067210901900618","article-title":"Conversion from nonischemic to ischemic retinal vein occlusion: prediction by venous velocity on color doppler imaging.","volume":"19","author":"Arsene","year":"2009","journal-title":"Eur J Ophthalmol"},{"key":"R23-20260805","first-page":"1","article-title":"Argon laser scatter photocoagulation in treatment of branch retinal vein occlusion. A prospective clinical trial.","volume":"206","author":"Hayreh","year":"1993","journal-title":"Ophthalmologica"},{"key":"R24-20260805","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.2174\/1381612821666150225120314","article-title":"Anti-VEGF drugs in eye diseases: local therapy with potential systemic effects.","volume":"21","author":"van der Giet","year":"2015","journal-title":"Curr Pharm Des"},{"key":"R25-20260805","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.drudis.2019.05.034","article-title":"Potential antiedematous effects of intravitreous anti-VEGF, unrelated to VEGF neutralization.","volume":"24","author":"Behar-Cohen","year":"2019","journal-title":"Drug Discov Today"},{"key":"R26-20260805","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/aos.12772","article-title":"Anti-VEGF treatment in branch retinal vein occlusion: a real-world experience over 4 years.","volume":"93","author":"Rezar","year":"2015","journal-title":"Acta Ophthalmol"},{"key":"R27-20260805","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/s41433-021-01620-z","article-title":"Long-term outcomes of anti-VEGF treatment of retinal vein occlusion.","volume":"36","author":"Spooner","year":"2022","journal-title":"Eye (Lond)"},{"key":"R28-20260805","doi-asserted-by":"crossref","first-page":"432685","DOI":"10.1155\/2014\/432685","article-title":"The role of inflammation in the pathogenesis of macular edema secondary to retinal vascular diseases.","volume":"2014","author":"Ascaso","year":"2014","journal-title":"Mediators Inflamm"},{"key":"R29-20260805","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/02713683.2014.1002048","article-title":"Dexamethasone intravitreal implant for chronic diabetic macular edema resistant to intravitreal bevacizumab treatment.","volume":"41","author":"Totan","year":"2016","journal-title":"Curr Eye Res"},{"key":"R30-20260805","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.thromres.2022.11.009","article-title":"Adjusted global antiphospholipid syndrome score (aGAPSS) is useful to predict relapses in patients with retinal vein occlusion.","volume":"221","author":"Hern\u00e1ndez","year":"2023","journal-title":"Thromb Res"},{"key":"R31-20260805","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/09273948.2011.582219","article-title":"Branch retinal artery occlusion associated with beh\u00e7et disease.","volume":"19","author":"Yahia","year":"2011","journal-title":"Ocul Immunol Inflamm"},{"key":"R32-20260805","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.2147\/OPTH.S33456","article-title":"Impending anterior ischemic optic neuropathy with elements of retinal vein occlusion in a patient on interferon for polycythemia vera.","volume":"6","author":"Rue","year":"2012","journal-title":"Clin Ophthalmol"},{"key":"R33-20260805","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4103\/ijo.IJO_340_16","article-title":"Combined branch retinal vein and branch retinal artery occlusion - clinical features, systemic associations, and outcomes.","volume":"65","author":"Sengupta","year":"2017","journal-title":"Indian J Ophthalmol"},{"key":"R34-20260805","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/aos.14141","article-title":"Association of glaucoma with risk of retinal vein occlusion: a meta-analysis.","volume":"97","author":"Yin","year":"2019","journal-title":"Acta Ophthalmol"},{"key":"R35-20260805","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.3390\/ijms20205214","article-title":"Endothelial dysfunction in primary aldosteronism.","volume":"20","author":"Chen","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R36-20260805","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/ICB.0000000000000611","article-title":"Conn syndrome presenting as central retinal vein occlusion.","volume":"14","author":"Atik","year":"2020","journal-title":"Retin Cases Brief Rep"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000046990","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T17:02:00Z","timestamp":1785949320000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000046990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046990","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"2025-01-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}